Mortgage Blog

A long-promised site and a tech-intensive concept are in the works for F.N.B.'s HQ city.

A national bank is accusing local biotech entrepreneur Cate Dyer of fraud and is suing her Folsom company StemExpress LLC over outstanding debt.

Rite Aid now lists 92 store leases and 21 fee-owned stores for sale as the pharmacy works through Chapter 11 bankruptcy.

What if your doctors knew you were genetically predisposed to a certain health condition and could treat you better – and perhaps even preventing the disease? That's the goal of Cone Health's latest initiative with Helix, a California startup that has raised $403 million and worked with the NIH and CDC. Find out about their new joint venture to test 100,000 Triad patients here.

Plymouth-based cancer research company Celcuity Inc. (NASDAQ: CELC) has raised $50 million in private investments.

Millan, a transplant surgeon by training, had been with CIRM since 2012 and its president and CEO since 2017.

The deal positions Surescripts to “make it simpler and faster to get patients started on the best medication for them,” its CEO said.

Fundraising has also been a challenge this year, but CEO Harvey Schwartz expects it to rebound this quarter.

Stonelake Capital Partners exceeded a $700 million target with its seventh fund before hitting a hard cap in total equity commitments, making it the largest fund raised by the firm since it launched in 2007. Click through to learn what type of properties Stonelake will target for development and acquisition, and to learn more about the institutional investors that put money into the fund.

There have long been five banks that have controlled two-thirds of the deposit market share in the Philadelphia region. Jennifer Roberts believes Chase can vault into that top five within the next decade.